-
公开(公告)号:US20220227764A1
公开(公告)日:2022-07-21
申请号:US17614067
申请日:2020-06-24
Applicant: UCB Biopharma SRL
Inventor: Anne Marie Foley , Fabien Claude Lecomte , James Thomas Reuberson , Matthew Duncan Selby , Richard David Taylor , Paul Jonathan Hickford , Gareth Neil Brace
IPC: C07D471/04
Abstract: A series of substituted fused bicyclic imidazole derivatives, including imidazo[1,2-a]pyridine derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.